COVID-19 reactivating CMV or CMV complicating COVID-19: A need to conquer
Saved in:
Main Authors: | Areena Hoda Siddiqui, Anju Shukla, Dayaram Yadav |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-07-01
|
Series: | Indian Journal of Pathology and Microbiology |
Online Access: | https://journals.lww.com/10.4103/ijpm.ijpm_211_22 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SPA14 liposomes combining saponin with fully synthetic TLR4 agonist provide adjuvanticity to hCMV vaccine candidate
by: Ernesto Luna, et al.
Published: (2024-12-01) -
Predicting cytomegalovirus infection and graft-versus-host disease using QuantiFERON-CMV and Monitor in pediatric transplants: a proof-of-concept study
by: Lina Souan, et al.
Published: (2025-02-01) -
Author Correction: SPA14 liposomes combining saponin with fully synthetic TLR4 agonist provide adjuvanticity to hCMV vaccine candidate
by: Ernesto Luna, et al.
Published: (2025-02-01) -
Vaccine administration during COVID-19 pandemic: an overview of safe injection technique and local complications
by: Wen Loong Paul Yuen, et al.
Published: (2023-11-01) -
COVID-19 and Nutrition
by: Farah Tadros, et al.
Published: (2022-02-01)